"我愿意这样做":理解在性化药物使用的背景下道德代理,同情和耻辱感
Daryl Mangosing1, Evan van Dommelen-Gonzalez2, Mark Fleming2
1College of Nursing, Florida State University, Tallahassee, FL, USA.
Culture, health & sexuality
|March 15, 2026
概括
这项研究探讨了道德选择权,同情心和社区支持如何影响性化药物使用者的危害减少. 调查结果强调了减轻耻辱和促进健康的集体责任和同情心.
科学领域:
- 公共卫生 公共卫生
- 社会学 社会学 社会学
- 心理学 心理学 心理学
背景情况:
- 性化药物使用研究往往忽视了诸如道德代理和减少伤害等社会/伦理维度.
- 对于这个群体中道德代理,同情和耻辱的相互作用,人们的理解有限.
研究的目的:
- 检查从事性化药物使用的个体之间的道德选择权,同情和耻辱之间的关系.
- 了解社会和伦理因素影响该社区的减少危害实践.
主要方法:
- 质量研究涉及18个半结构化的深度访谈.
- 参与者是加利福尼亚州居民 (>18岁) 在过去六个月 (不包括酒精) 中在性行为时使用药物.
- 通过移动连接应用程序,网站和雪球采样进行招聘,重点是异性恋同性恋男性.
主要成果:
- 参与者讨论了对健康的个人和共同责任,知情的物质使用,以及依赖支持网络.
- 共感被认为是创造包容性环境和减少内化和外化耻辱的关键因素.
- 减少危害的做法是以关键的社会和道德因素为基础的,包括社区支持和集体责任.
结论:
- 亲社会干预应适应社区内部的需求,强调社区的支持,同情心和集体责任.
- 建议制定反公共卫生框架,以指导未来对性化药物使用者的减少危害的努力.
- 解决耻辱和促进健康需要了解减少伤害实践的社会和伦理层面.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Motivational Bias
461
Cognitive bias results from limitations in thinking and information processing, leading to systematic errors in judgment. Conversely, motivational bias stems from personal desires or emotions, causing distortions in perception to align with self-interest. Motivational bias influences how individuals perceive and attribute causes to events, often shaped by personal needs, goals, and self-esteem preservation. This bias can distort judgment, leading to inaccurate assessments of success, failure,...
461
Drug Dependence
1.8K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.8K
An Overview of Psychoactive Drugs
745
Psychoactive drugs impact brain function, influencing perception, mood, consciousness, cognition, and behavior. These substances are grouped based on their effects and the mechanisms by which they act.
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
Stimulants such as cocaine, amphetamines, and nicotine enhance brain activity, leading to increased alertness, attention, and energy. These drugs typically raise heart rate, blood pressure, and body temperature. While they can induce feelings of euphoria, their misuse can result in severe health...
745
CNS Stimulants: Psychedelic Agents
945
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
945
Drug Control Governance: Regulatory Bodies and Their Impact
638
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
638


